Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Public ClinicalTrials.gov record NCT03547206. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION
Study identification
- NCT ID
- NCT03547206
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Regenera Pharma Ltd
- Industry
- Enrollment
- 165 participants
Conditions and interventions
Interventions
- Placebo Cohort A Other
- Placebo Cohort B Other
- RPh201 Cohort A Drug
- RPh201 Cohort B Drug
Other · Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 9, 2018
- Primary completion
- Sep 26, 2020
- Completion
- Sep 26, 2020
- Last update posted
- Oct 11, 2020
2018 – 2020
United States locations
- U.S. sites
- 15
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Byers Eye Institute at Stanford University | Palo Alto | California | 94303 | — |
| UCLA Doheny Eye Center | Pasadena | California | 91105 | — |
| The Eye Care Group | Orange | Connecticut | 06477 | — |
| The Eye Care Group | Waterbury | Connecticut | 06708 | — |
| Anne Bates Leach Eye Hospital/Bascom Palmer Eye Institute | Miami | Florida | 33136 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| NorthShore Medical Group | Glenview | Illinois | 60026 | — |
| Bethesda Neurology, LLC | Rockville | Maryland | 20852 | — |
| Massachusetts Eye and Ear Infirmary | Boston | Massachusetts | 02114 | — |
| Washington University Ophthalmology | St Louis | Missouri | 63108 | — |
| New York Eye and Ear Infirmary of Mount Sinai | New York | New York | 10003 | — |
| Wills Eye Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Charleston Neuroscience Institute | Ladson | South Carolina | 29456 | — |
| Neuro-Eye Clinical Trials, Inc. | Houston | Texas | 77005 | — |
| University of Virginia | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03547206, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 11, 2020 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03547206 live on ClinicalTrials.gov.